TrendFlares logo

Acurx Pharmaceuticals, Inc. (ACXP)

$2.51 0.00% $0.00 Healthcare

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

$39.77M

Mr. David P. Luci CPA, CPA, Esq., J.D.

4.00

Staten Island, NY

Jun 15, 2021

-2.13

$-1.18

2.87

2.93

0.00%

-2.42

-0.10

6.47

0.00

2.87

-176.23%

-308.46%

Downtrend

Similar stocks (10)

Aerovate Therapeutics, Inc.

AVTE

$17.45 -1.19%
Downtrend

Candel Therapeutics, Inc.

CADL

$8.90 3.25%
Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$7.72 1.98%
Neutral

Rezolute, Inc.

RZLT

$4.03 -2.89%
Uptrend

PMV Pharmaceuticals, Inc.

PMVP

$1.82 1.68%
Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.99 -2.45%
Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.05 -2.38%
Downtrend

Lumos Pharma, Inc.

LUMO

$2.25 -1.75%
Downtrend

Monopar Therapeutics Inc.

MNPR

$0.61 -0.23%
Neutral

Silo Pharma, Inc.

SILO

$2.08 4.00%
Uptrend

ETF Exposure (6)

iShares Micro-Cap ETF

IWC

0.00458%

$117.50 0.41%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$128.59 0.27%
Neutral

Vanguard Total Stock Market Index Fund

VITSX

0%

$126.75 0.74%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$260.44 0.77%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$126.73 0.74%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$169.62 0.38%
Uptrend